ADME Toxicology Testing Market Size, Share, Trends, and Forecast 2026-2034 | USD 30.7 Billion by 2034 at 11.2% CAGR as AI and In-Vitro Models Reshape Drug Development

Boost ROI through early predictive testing, AI-driven automation, CRO outsourcing, strategic partnerships, and expansion into high-growth regionsDublin, Oct. 06, 2026 (GLOBE NEWSWIRE) -- "ADME ...

Global Early Toxicity Testing Market Size, Share, and Forecast 2026-2034 | AI and Non-Animal Methods Drive 6.57% CAGR, Creating a USD 2.6 Billion Opportunity

AI-driven predictive toxicology, in vitro and organ-on-chip testing cut costs, accelerate screening, reduce animal use and prevent costly late-stage drug failuresDublin, Oct. 06, 2026 (GLOBE NEWSWIRE) ...

Cloud-Clone Primary Cardiac Cells: High-Fidelity In-vitro Models for Cardiovascular Research and Drug Evaluation

Overcoming Limitations of Immortalized Cell Lines and Animal Models to Boost Translational Cardiovascular Science ...
BIOENGINEER

Single-Dose Drug Acoziborole Shows Promise Against Both Forms of Sleeping Sickness

New laboratory evidence shows the single-dose oral drug acoziborole is as potent against the rarer rhodesiense form of ...
People for the Ethical Treatment of Animals (PETA)

PETA Science Group, IIVS, and Indian Labs Join Forces to Advance Non-Animal Toxicity Testing

PETA Science Consortium International e.V. and the Institute for In Vitro Sciences co-organized first-of-their-kind, hands-on ...

ProMed Pharma Examines How Material Selection Shapes Release Behavior in Polymeric Drug Delivery

Material selection can influence far more than the physical form of a controlled-release dosage form. In polymeric drug delivery, the polymer system can affect how an active pharmaceutical ingredient ...
Medical Device Network on MSN

Roche’s TIB MOLBIOL introduces in vitro newborn screening test kit

The assay operates on LightCycler systems and evaluates samples simultaneously for SCD, SMA, and SCID.
Nature

Drug safety articles from across Nature Portfolio

A phase 1b trial shows that IBC-Ab002, a short-lived antibody that intermittently activates the peripheral immune system, is safe and well tolerated with trends in biomarkers in people with early ...
BIOENGINEER

Simulated Patients Replace Human Trials in Virtual Test of Roxithromycin Drug Equivalence

Chinese researchers validated a physiologically based pharmacokinetic model of roxithromycin and used it to run a virtual bioequivalence trial in 99 simulated East Asian subjects, finding two ...
What If on MSNOpinion

Animal testing could end, but scientists would face a huge problem

Experimenting on animals is a dark side of science and research. And most of us try not to think about the animals that ...

XtalPi Details Kodexia AI Platform for siRNA Drug Discovery

XtalPi’s Kodexia combines generative AI and automated lab testing for siRNA drug discovery. Explore its workflow, reported ...

Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model

Second-generation oral mucosal vaccine candidate (VXA-H5-02) induced robust cross-neutralizing antibodies, significantly reduced viral load, and ...